Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Gammagard

Promising Alzheimer’s Drug Fails in Study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer’s disease.

The company says that people who received 18 months of infusions with its drug, Gammagard, fared no better than others… Promising Alzheimer’s Drug Fails in Study   



Going Home (A short film on Dementia)

blast-induced traumatic brain injury1 - chronic sleep deprivation1 - brain imaging1 - alzheimer's population1 - confusion3 - berrios and freeman1 - berrios2 - world alzheimers day1 - frontal dementia1 - alzheimers symptoms1 - exelon1 - brain plaques1 - abeta plaque1 - symptoms of parkinson's3 - long-term dementia1 - anticholinergics1 - carl schneider1 - professor lewy1 - hypomanic1 - protective effect1 - elder care1 - dopamine6 - alzheimer2 - department of psychiatry and psychotherapy1 - insulin-like growth factor-11 - neuropsychological tests1 - brewer1 - korsakoff's psychosis5 - magnetic resonance spectroscopy1 - aphasia4 -